Skyrizi (risankizumab) stays in your system for roughly 4 to 5 months after your last dose. The drug has a terminal half-life of about 28 days, meaning it takes approximately that long for your body to clear half the medication from your blood. Using the standard pharmacology rule of five half-lives for near-complete elimination, that works out to about 140 days, or just under 5 months, before the drug is essentially gone.
How Skyrizi Leaves Your Body
Skyrizi is a large, lab-made antibody protein. Unlike small-molecule pills that your liver and kidneys break down, antibody drugs are cleared gradually through a process called proteolysis, where your body’s cells slowly break the protein into smaller amino acid fragments and recycle them. This is the same way your body handles its own natural antibodies, which is why the process is slow and predictable.
The FDA label lists a half-life of approximately 28 days for people with plaque psoriasis and approximately 21 days for people with Crohn’s disease. The difference likely reflects the higher intravenous induction doses used in Crohn’s treatment and variations in how the drug distributes across tissues in each condition. For psoriasis patients, five half-lives equals about 140 days. For Crohn’s patients, it’s closer to 105 days.
What “Out of Your System” Actually Means
There’s an important distinction between when the drug becomes undetectable in your blood and when its effects wear off. Skyrizi works by blocking a specific immune signaling protein called IL-23. Even after blood levels of the drug drop very low, the downstream effects on your immune system can persist for months. In one study, people who stopped receiving Skyrizi still showed suppressed immune markers 52 weeks after their last dose, a sign that the drug’s impact on the immune pathway outlasts the drug itself.
This is good news if you’re worried about a gap between doses. Missing a scheduled injection by a few weeks doesn’t mean your protection vanishes overnight. But it also means that if you’re stopping the drug for a specific reason, like preparing for a live vaccine, the relevant window may be longer than the 4 to 5 months it takes for the molecule to clear.
When Symptoms Typically Return After Stopping
For people with psoriasis who stop Skyrizi after achieving clear or nearly clear skin, the timeline for flare-ups is surprisingly long. In clinical data, the median time to losing a complete skin clearance response was about 36 weeks (roughly 9 months) after discontinuation. People who had achieved a 90% improvement in their psoriasis scores held that level of response for a median of 42 weeks, about 10 months.
Some people maintained meaningful improvement for even longer. The median time before skin worsened to a moderate level was roughly 54 weeks, just over a year. These timelines vary widely from person to person, but they confirm that Skyrizi’s clinical benefits extend well beyond the point when the drug itself has left your bloodstream. Your immune system doesn’t snap back to its pre-treatment state the moment drug levels drop to zero.
Factors That Affect Clearance Speed
Body weight is the most significant variable. People who weigh more tend to clear Skyrizi faster and have lower blood concentrations of the drug, while lighter individuals clear it more slowly. Despite this variation, the FDA does not recommend any dose adjustment based on weight because the differences aren’t large enough to meaningfully change how well the drug works.
Unlike many medications, Skyrizi is not processed through the liver or filtered by the kidneys in the traditional sense. Because it’s broken down by general protein recycling throughout the body, liver disease and kidney impairment are not expected to significantly alter how long the drug stays in your system. This is a notable difference from most conventional drugs, where organ function plays a major role in clearance timing.
Reaching and Leaving Steady State
If you’ve been on Skyrizi for a while, your body reaches a steady state, where the amount entering your system with each dose roughly equals the amount being cleared, by about week 16 of treatment. At steady state, there’s more total drug in your body than after a single dose, which means the 4 to 5 month clearance clock starts from a higher baseline. In practice, this doesn’t dramatically change the overall elimination timeline because the drug follows linear pharmacokinetics: it clears at a consistent, proportional rate regardless of how much is present.
For someone who received only one or two doses before stopping, clearance would be somewhat faster simply because there’s less drug accumulated in the body. For someone who has been on the standard dosing schedule for a year or more, the full 140-day estimate is the most accurate guide.